Nov 15 (Reuters) - Capitol Health Ltd CAJ.AX -
* Ebitda of group for December 2016 half year is likely to be in range of $7.7m to $8.2m
* Capitol's revenue was below expectations and likely to result in revenue for half year in range of $79 to $80m
* Board is also undertaking a review of non-core investments which is expected to be complete by end of half
* Capital expenditure has also been reduced resulting in an expected spend below $5m for 2017 financial year Source text for Eikon: ID:nASX4cQPCZ Further company coverage: CAJ.AX